Sabra Health Care

Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Sabra Health Care reports strong Q4 performance amidst Enlivant JV challenges

Sabra Health Care showcased improved performance in occupancy rates and revenue growth, with a strategic focus on senior housing opportunities.
Despite challenges from the Enlivant JV impact and market uncertainties, Sabra's strengths in debt management and asset operations position it well for future growth.
Opportunities lie in securing interest rates, expanding in the senior housing sector, and resolving uncertainties around the Enlivant JV for strategic advancement.
Addressing challenges such as transaction market dynamics and maintaining growth momentum will be crucial for Sabra's continued success in the healthcare real estate sector.

Sabra Health Care reports stable Q1 performance amidst market challenges

Sabra Health Care's Q1 2023 performance reflects stability and operational improvements in skilled nursing and senior housing portfolios.
While facing challenges in investment activity and rising debt financing rates, the company is leveraging opportunities in Medicaid rate increases and strategic investments.
Maintaining financial strength and flexibility, Sabra Health Care is poised to navigate market uncertainties and drive operational efficiency.

Sabra Health Care reports robust Q2 performance and eyes 2024 growth

Sabra Health Care's Q2 2023 earnings call highlighted positive performance metrics, ongoing margin recovery efforts, and strategic initiatives to drive occupancy and revenue growth. Despite challenges in the IL segment and market dynamics, the company's strong financial position and focus on portfolio optimization position it well for future opportunities.

Sabra Health Care posts robust Q3 results, eyes growth opportunities

Sabra Health Care's Q3 2023 earnings call reflects strong performance, portfolio stability, and growth potential. Challenges include maintaining coverage ratios and addressing analyst concerns. Opportunities exist in acquisitions, financing, and leveraging portfolio momentum.

Sabra Health Care reports strong Q4 performance and eyes industry growth opportunities

Sabra Health Care showcased strong performance in occupancy and financial metrics, with a focus on operational improvements and growth strategies.
While facing challenges related to occupancy levels and construction costs, the company remains optimistic about industry recovery and growth potential.
Opportunities in the skilled nursing space and sale-leaseback investments present avenues for expansion and strategic development.
Analysts' inquiries and discussions on acquisitions, regulatory issues, and financial guidance reflect a dynamic landscape with potential for strategic advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Sabra Health Care REIT, Inc. (SBRA) CEO Rick Matroson Q2 2020 Results - Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of 12.50% and 5.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Q2 FFO and Revenues Beat Estimates

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Sabra Health Care REIT, Inc.

Sabra Reports Second Quarter 2020 Results; Provides a Business Update

IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. to Participate in Virtual Investor Access Offering hosted by MUFG Union Bank

Sabra Health Care REIT, Inc. Announces Second Quarter 2020 Earnings Release Date and Conference Call

Sabra: This Top 10 Stock Shows Resilience, Investment Potential With Attractive Valuation

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Fitch Ratings has affirmed the ratings for Sabra and its subsidiaries at 'BBB-'; Fitch Rating’s Outlook of Negative also remains unchanged. The report notes Sabra's headroom for leverage, portfolio quality and diversification, strong liquidity due to no near-term maturities, improving access to capital and average operator lease coverage as key drivers for its ratings decisions. The full report can

Fitch Ratings Affirms Sabra’s Credit Rating and Outlook

Sabra Health Care REIT, Inc.(SBRA) CEO Rick Matroson Q1 2020 Results - Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of 2.27% and -3.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Tops Q1 FFO Estimates

Sabra Health Care: Priced For A Sale

Sabra Health Care REIT, Inc. (SBRA) CEO Rick Matros on Q4 2019 Results - Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of 4.44% and 3.52%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Surpasses Q4 FFO and Revenue Estimates

Ares Capital

DoubleLine Income Solutions Fund

Macy's

Macquarie Infrastructure

New Residential Investment

NuStar Energy

Park Hotels & Resorts

It may sound old to read that investors love dividends. That is something the public is just going to have to learn to deal with.

8 Dividend Picks With at Least 8% Yields and Projected Upside for 2020

Sabra Health Care REIT, Inc. (SBRA) CEO Rick Matros on Q3 2019 Results - Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of 2.17% and -2.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Surpasses Q3 FFO Estimates

Sabra Health Care (SBRA) restates unsecured credit facility aggregating $2.2 billion, which will improve its debt maturities laddering. The company has no significant expirations until 2022.

Sabra (SBRA) Amends $2.2B Credit Facility, Extends Maturities

Sabra Health Care REIT, Inc. (SBRA) CEO Rick Matros on Q2 2019 Results - Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of -2.13% and 35.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Q2 FFO Miss Estimates

Sabra is going through the last stages of its transition to a more diversified portfolio and sounder balance sheet.

Sabra: Improved Compensation Policy To Spur Value Creation

Sabra Health Care REIT, Inc. (SBRA) CEO Rick Matros on Q1 2019 Results - Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of -4.00% and -5.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

News for Sabra Health Care Stock (SBRA)